Alexandra Shimmings on Muck Rack

Alexandra Shimmings

Verified
London
As seen in: In Vivo, Scrip, The Pink Sheet, BioXconomy, Citeline, Generics Bulletin, HBW Insight, Medtech Insight, BioProcess International Magazine
While most people think it's our brain that controls our actions, it's often our heart that gets the biggest workout
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Alexandra

Contact Alexandra, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Alexandra Shimmings’s Biography

Read Full Bio →

Alex has 19 years' experience in writing about the pharmaceutical industry, specialising in drug development, clinical trials and data.

Articles

Scrip’s Guide To The Month Ahead: July 2026

|
By Alexandra Shimmings Verified
| Scrip Verified
After a busy June of major medical conferences, the pace slows down for July, but although late-breaking abstracts are not yet available, there will be some interesting studies presented for peer review. The month starts with the ESMO World Congress on GI Cancer in Munich, Germany, where Revolution Medicines is reporting further...
Open in Who Shared Issue with article?

Pharma Sales To Top $2 Trillion As The Big Drug Era Beds In

|
By Alexandra Shimmings Verified
| Scrip Verified
Powered by the obesity gold rush and led by Eli Lilly's record-breaking tirzepatide, Evaluate's 2026 World Preview shows that pharma is set to break the new sales barriers in the coming years. Global pharmaceutical sales are set to surpass the $2tn mark by 2032, driven largely by drugs for obesity and inflammatory diseases.
Open in Who Shared Issue with article?

China Puts Its Stamp On A Record-Breaking Year For Novel Drug Launches

|
By Alexandra Shimmings Verified
| Scrip Verified
China Puts Its Stamp On A Record-Breaking Year For Novel Drug Launches The highest ever number of new active substance launches in 2025 came after China outstripped the US as the market with the most drug debuts. Key Takeaways A record number of novel drug were launched in 2025, with the number reaching 105. 2025 was a watershed moment for biopharma with China for the first time outpacing the US for the number of...
Open in Who Shared Issue with article?
See all 545 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified